✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Stocks That Could 10X Over the Next 10 Years

In this article, we will take a look at the 10 Stocks That Could 10X Over the Next 10 Years.

The last few years have been incredible for stock investors, with the S&P 500 returning 86% between 2023 and 2025. However, valuations have progressively increased over the past three years, and the sustainability of corporate earnings may be of concern in 2026.

Following the latest stock market decline, the S&P 500 is now trading at approximately 20.6 times aggregate forward earnings estimates. That’s still substantially over its long-term average of mid- to high teens, but significantly lower than the 22x earnings multiple it traded at at the beginning of the year.

Meanwhile, consumer confidence in the US is declining. According to a new University of Michigan survey, consumer mood fell across age groups, political parties, and income levels in March. The survey portrays an ominous state of how Americans are contending with the economic consequences of the Iran conflict.

That said, Mike Wilson, Morgan Stanley’s chief US equity strategist, says the market decline is “as significant” as those in 2015 and 2023. Simultaneously, earnings growth is predicted to rise to 17% over the next 12 months. According to Wilson’s study, when these two patterns aligned in previous years, the S&P 500 gained a median 10% over the following six months, exceeding the long-term average of 5%.

With that, let’s look at the 10 stocks that could 10x over the next 10 years.

Our Methodology

To compile a list of stocks that could 10x over the next 10 years, we used multiple financial websites, including EBC Financial, Nasdaq, Yahoo Finance, and Motley Fool. These stocks hold the potential to be tenbaggers, and are also popular among analysts and elite hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

10. Rigetti Computing Inc. (NASDAQ:RGTI)

Rigetti Computing Inc. (NASDAQ:RGTI) ranks among the stocks that could 10x over the next 10 years. Following Rigetti Computing Inc.’s fourth-quarter fiscal 2025 results, Rosenblatt reiterated a Buy rating and a $40 price target for the company’s shares on March 5. The company’s EPS of -$0.03 was in line with analyst expectations, but revenue totaled $1.9 million, considerably lower than the expected $2.32 million.

The company stated that it had rectified the fidelity issue on the Cepheus-1-108Q machine and intends to ship it at the ideal 99.5% by the end of March. Rosenblatt stated that the comparatively swift resolution of the technical issue highlights the advantages of Rigetti having its own fabrication facility.

Meanwhile, Needham maintained a Buy rating on Rigetti Computing Inc. while lowering its stock price target from $51 to $31, citing sector compression. In addition, the firm raised Rigetti’s fiscal 2026 revenue estimate from $18.5 million to $21.0 million, citing increasing system sales as a driving force.

Rigetti Computing Inc. is a quantum computing and semiconductor hardware company that designs and builds superconducting quantum processors. Through its cloud-based platform, the company provides quantum-computing-as-a-service to commercial, academic, and government partners.

9. Ferrari NV (NYSE:RACE)

Ferrari NV (NYSE:RACE) ranks among the stocks that could 10x over the next 10 years. Evercore ISI reaffirmed its Outperform rating and $475.0 price target for Ferrari NV on March 19. The firm stated that Ferrari will most likely lower its projections for the first half of 2026 and offer further information on how the Middle East war may affect 2026 earnings if it lingers into the second half of the year.

According to Evercore ISI, Ferrari NV typically builds enough support to outperform its initial revenue expectations by about 5%, though the firm added that Ferrari NV rarely raises expectations on the first-quarter call.

If the war is prolonged, the possibility of slower sales in the Middle East could increase, which might limit any near-term upside to 2026 figures. However, the firm believes there is little risk of negative adjustments in the near term and that this will demonstrate the adaptability that Ferrari’s global supply model allows during disputes.

Ferrari NV, more commonly known as Ferrari, is an Italy-based manufacturer, designer, and retailer of luxury sports cars. It also produces one-off and limited-series cars and operates under the Ferrari brand.

8. Rivian Automotive, Inc. (NASDAQ:RIVN)

Rivian Automotive, Inc. (NASDAQ:RIVN) ranks among the stocks that could 10x over the next 10 years. Following the announcement of a cooperation with Uber Technologies Inc., Stifel reaffirmed its Buy rating and $20 price target for Rivian Automotive, Inc. on March 19. The partnership will result in the deployment of as many as 50,000 fully autonomous R2 vehicles, with a starter rollout of about 10,000 vehicles starting in 2028 and the option to buy up to 40,000 more R2s beginning in 2030.

The company plans to roll out thousands of unmanned R2 robotaxis in around 25 cities across the US, Canada, and Europe around 2031. In that vein, Uber intends to invest up to $1.25 billion, with around $300 million already allocated.

According to analyst Stephen Gengaro, the collaboration offers “a meaningful positive for Rivian’s autonomous capabilities and the expansion of its R2 platform.”

Rivian Automotive, Inc. designs, develops, and manufactures category-defining electric vehicles and accessories. Its operations are divided into the following segments: Automotive, Software, and Services.

7. Joby Aviation Inc. (NYSE:JOBY)

Joby Aviation Inc. (NYSE:JOBY) ranks among the stocks that could 10x over the next 10 years. Canaccord Genuity reaffirmed its Hold rating and $15.50 price target for Joby Aviation Inc. on March 12, following the company’s disclosure of a major accomplishment in its aircraft testing program. Joby Aviation Inc. stated that its first conforming aircraft for Type Inspection Authorization testing conducted its first test flight in Marina, California.

The company anticipates that this aircraft and five other planes in assembly will commence TIA testing with FAA pilots for credit later in 2026. Joby Aviation Inc. corporate pilots will conduct ground and flying exams before FAA pilots.

Canaccord sees the impending TIA flight tests, conclusion of the Means of Compliance for the S4 eVTOL, and beginning of eIPP flight tests in the latter half of 2026 as key investor triggers for the company this year.

Joby Aviation Inc. is an air mobility company that researches, develops, tests, manufactures, and sells electric vertical takeoff and landing aircraft in the US, Japan, Europe, and internationally.

6. CRISPR Therapeutics AG (NASDAQ:CRSP)

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its price target for CRISPR Therapeutics AG to $110 from $105 on March 17, retaining an Overweight rating in response to the company’s convertible note issuance. CRISPR Therapeutics AG raised $600 million in convertible notes due in March 2031, convertible at $76.56 per share and with an effective interest rate of 1.73%. The company also allowed initial purchasers to pick up an extra $50 million in notes, with the transaction set to finalize in March of this year.

Moreover, CRISPR Therapeutics AG plans to disclose Phase I data on zugo-cel in autoimmune diseases and B-cell lymphoma in the latter half of 2026. The company also plans to begin Phase I research on CTX340 in the first half of 2026 and CTX460 in mid-2026.

Meanwhile, in the second half of 2026, CRISPR Therapeutics AG will provide Phase Ib data on CTX310 and proof-of-concept Phase II data on CTX611 in patients undergoing total knee replacement.

CRISPR Therapeutics AG is a leader in gene-editing technology, using its proprietary gene sequencing platform to develop precise treatments for diseases requiring DNA modification.

5. Rocket Lab Corporation (NASDAQ:RKLB)

Rocket Lab Corporation (NASDAQ:RKLB) ranks among the stocks that could 10x over the next 10 years. On March 18, Rocket Lab Corporation reported that it had signed a $190 million contract for 20 hypersonic test flights utilizing its HASTE launch platform, which is the company’s largest launch arrangement to date. The agreement is a component of the US Department of War’s Multi-Service Advanced Capability Hypersonic Test Bed 2.0 program.

Since 2023, Rocket Lab Corporation has successfully executed numerous HASTE launches at speeds exceeding Mach 5 for the MACH-TB program, achieving a 100% mission fulfillment rate.

On the same day, Clear Street began coverage of Rocket Lab Corporation, with a Buy rating and a price target of $88. The firm described the company’s vertically integrated architecture as an edge that competes with some of SpaceX’s services, the industry leader.

Rocket Lab Corporation is a space company that provides launch services and space systems solutions in the US, Canada, Japan, and internationally. The company operates through launch services and space systems segments.

4. Oklo Inc. (NYSE:OKLO)

Oklo Inc. (NYSE:OKLO) ranks among the stocks that could 10x over the next 10 years. Following Oklo Inc.’s fourth-quarter operating updates spanning its power, fuel, and isotopes businesses, William Blair maintained an Outperform rating on the company on March 18. Oklo Inc. reported solid results in its fourth-quarter and fiscal-year 2025 updates, with roughly $2.6 billion in pro forma liquidity, eliminating short-term funding risk.

The company also announced that the Aurora reactor gained its initial design clearance from the Department of Energy, lowering the risk of Oklo’s power deal with Meta to deliver 1.2 gigawatts by 2034.

Meanwhile, Needham decreased its price target for Oklo Inc. to $73 from $135 while retaining a Buy rating on the stock. According to the firm, the price target was dropped due to lower outer-year deployment forecasts and a lower valuation multiple. Needham now expects around 3 gigawatts of deployment by 2035.

Oklo Inc. is an advanced nuclear technology company developing fast fission power plants, isotope production capabilities, and nuclear fuel recycling technologies.

3. C3.ai, Inc. (NYSE:AI)

C3.ai, Inc. (NYSE:AI) ranks among the stocks that could 10x over the next 10 years. On March 2, C3.ai, Inc. CEO Stephen Ehikian outlined the company’s strategic recovery plan at the Morgan Stanley Technology, Media, and Telecom Conference 2026. The company is focusing on industrial and federal AI applications to improve its competitive position.

C3.ai, Inc. is going through a significant restructure, including a 26% labor decrease to cut costs and improve performance. Despite margin pressure, currently at the mid-50% level vs historical 70%, the company’s balance sheet is solid, with $620 million in cash and no debt.

According to Ehikian, C3.ai’s development will be driven by major AI transformation engagements and recurring revenue, as well as strategic collaborations. Its relationship with Microsoft has already resulted in $130 million in bookings and over 100 agreements.

C3.ai, Inc. is an enterprise artificial intelligence software company involved in building and operating enterprise-scale AI applications and accelerating digital transformation.

2. UiPath, Inc. (NYSE:PATH)

UiPath, Inc. (NYSE:PATH) ranks among the stocks that could 10x over the next 10 years. On March 16, BMO Capital reduced its price target for UiPath, Inc. to $14 from $17, retaining a Market Perform rating on the company’s shares. The company achieved a strong close to fiscal year 2026, exceeding high-end forecasts on key measures.

The company reported sustained stabilization in net new ARR, indicating improved execution and a healthier growth profile. In addition, UiPath, Inc. provided a fiscal 2027 ARR growth estimate of roughly 10.8%, projecting net new ARR of $200 million vs $187 million in the previous fiscal year.

BMO Capital increased its fiscal year 2027 ARR and revenue expectations slightly. The firm cited the $200 million AI-product ARR measure as encouraging. It also stated that investors will require further proof of ongoing AI monetization in order to stay loyal and support the company’s stock.

UiPath, Inc. is a software company focused on automation and orchestration, offering a platform that helps organizations deploy and manage automated workflows, including AI agent-led processes, across enterprise systems.

1. Palantir Technologies Inc. (NASDAQ:PLTR)

Palantir Technologies Inc. (NASDAQ:PLTR) ranks among the stocks that could 10x over the next 10 years. On March 19, Mizuho reaffirmed its Outperform rating and $195 price target for Palantir Technologies Inc..

The firm recently hosted discussions with Peter Czimback, Independent Advisor to the Palantir CFO, and a current Palantir customer. During the conversations, the executives focused on operational use cases, Palantir’s strategy regarding enterprise growth, and the lack of a similar alternative.

According to Mizuho, Palantir Technologies Inc. promises total revenue growth and margin expansion on a massive scale. The firm is optimistic about a thriving US Commercial business, backed by expanding enterprise adoption of AIP and an increasing need to deploy AI.

Moreover, the company has announced a number of collaborations, including an agreement with Moder to develop an AI-powered mortgage operations application with Freedom Mortgage serving as the first pilot client. Palantir Technologies Inc. has also teamed with Ondas Holdings Inc. and World View Enterprises to create AI-enabled surveillance, reconnaissance, and intelligence gathering capabilities.

Palantir Technologies Inc. is a software company that builds platforms such as Gotham and Foundry that help governments and businesses integrate, analyze, and act on large datasets using AI and machine learning, supporting sectors ranging from defense to healthcare, finance, and automotive.

Follow Insider Monkey on Google News.